Colorectal cancer screening

Czech version

Authors: Štěpán Suchánek; Tomáš Grega; Miroslav Zavoral
Authors‘ workplace: Interní klinika 1. LF UK a ÚVN – Vojenské fakultní nemocnice Praha
Published in: Vnitř Lék 2018; 64(6): 679-683
Category: Reviews

Overview

In developed countries, colorectal cancer represents one of the most common malignancy. Screening of colorectal cancer, as a tool of secondary prevention, lead to reduction of the incidence and mortality of this disease. It allows to capture not only the precancerous lesions, but also the earlier stages of colorectal cancer, which can be effectively treated. In the Czech Republic the National colorectal cancer screening program was launched in 2000. It is focused to asymptomatic individuals over 50 years old, who have a negative personal and family history of colorectal neoplasia. The basic tools of colorectal cancer screening in the Czech Republic include fecal occult blood test and colonoscopy. Introduction a population based screening program by addressed invitation in 2014 led to increase the participation of the target population for screening.

Key words:

address invitation – colorectal cancer – epidemiology – population based screening – screening tests

Sources

Dušek L, Májek O, Mužík J et al. Epidemiologie a populační screening nádorů tlustého střeva a konečníku v České republice na podkladě nově dostupných dat. Gastroent Hepatol 2015; 69(6): 509–517.
Conteduca V, Sansonno D, Russi S et al. Precancerous colorectal lesions (Review). Int J Oncol 2013; 43(4): 973–984. Dostupné z DOI: <http://dx.doi.org/10.3892/ijo.2013.2041>.
Suchanek S, Grega T, Ngo O et al. How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia? World J Gastroenterol 2016; 22(36): 8103–8111. Dostupné z DOI: <http://dx.doi.org/10.3748/wjg.v22.i36.8103>.
Ferlay J, Soerjomataram I, Dikshit R et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136(5): E359-E386. Dostupné z DOI: <http://dx.doi.org/10.1002/ijc.29210>.
Ústav zdravotnických informací a statistiky ČR. Národní onkologický registr (NOR). Dostupné z WWW: <www.uzis.cz/registry-nzis/nor>.
Pavlík T, Májek O, Büchler T et al. Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000–2008. Cancer Epidemiol 2014; 38(1): 28–34. Dostupné z DOI: <http://dx.doi.org/10.1016/j.canep.2013.11.002>.
van Rossum LG, van Rijn AF, Laheij RJ et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008; 135(1): 82–90. Dostupné z DOI: <http://dx.doi.org/10.1053/j.gastro.2008.03.040>.
Imperiale TF, Ransohoff DF, Itzkowitz SH et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004; 351(26): 2704–2714. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa033403>.
Segnan N, Armaroli P, Bonelli L et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial – SCORE. J Natl Cancer Inst 2011; 103(17): 1310–1322. <http://dx.doi.org/10.1093/jnci/djr284>. Erratum in J Natl Cancer Inst 2011; 103(24): 1903.
Heresbach D, Djabbari M, Riou F et al. Accuracy of computed tomographic colonography in a nationwide multicentre trial, and its relation to radiologist expertise. Gut 2011; 60(5): 658–665. Dostupné z DOI: <http://dx.doi.org/10.1136/gut.2010.225623>.
Rex DK, Adler SN, Aisenberg J et al. Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population. Gastroenterology 2015; 148(5): 948–957. Dostupné z DOI: <http://dx.doi.org/10.1053/j.gastro.2015.01.025>.
Carroll MR, Seaman HE, Halloran SP. Tests and investigations for colorectal cancer screening. Clin Biochem 2014; 47(10–11): 921–939. Dostupné z DOI: <http://dx.doi.org/10.1016/j.clinbiochem.2014.04.019>.
Atkin WS, Edwards R, Kralj-Hans I et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375(9726): 1624–1633. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140–6736(10)60551-X>.
El Zoghbi M, Cummings LC. New era of colorectal cancer screening. World J Gastrointest Endosc 2016; 8(5): 252–258. Dostupné z DOI: <http://dx.doi.org/10.4253/wjge.v8.i5.252>.
Kaminski MF, Polkowski M, Kraszewska E et al. A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut 2014; 63(7): 1112–1119. Dostupné z DOI: <http://dx.doi.org/10.1136/gutjnl-2013–304965>.
Zauber AG. The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Dig Dis Sci 2015; 60(3): 681–691. Dostupné z DOI: <http://dx.doi.org/10.1007/s10620–015–3600–5>.
Wilson JA. Colon Cancer Screening in the Elderly: When Do We Stop? Trans Am Clin Climatol Assoc 2010; 121: 94–103.